Literature DB >> 33633906

Relationship Between Pituitary Siderosis and Endocrinological Disorders in Pediatric Patients with Beta-Thalassemia.

Kamil Yılmaz1, Ahmet Kan2, Mehmet Guli Çetincakmak3, V Hulya Uzel4, Deniz Yılmaz5, Muhammed Akif Deniz6, Salih Hattapoglu6.   

Abstract

Introduction Excess iron accumulation occurs mainly in organs such as reticuloendothelial cells, the pituitary gland, and the pancreas in beta-thalassemia because of blood transfusions. In the present study, it was aimed to investigate the relationship between T2* values on magnetic resonance imaging (MRI) and clinically diagnosed pituitary endocrinological disorders in children with thalassemia major. Methods This study enrolled patients diagnosed with beta-thalassemia at pediatric hematology outpatient clinics. In the study, in addition to the medical history of the patients, routinely performed tests, including hemoglobin electrophoresis, routine biochemical tests, and tests for pubertal development (follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, testosterone, etc.), as well as iron deposition measured by hepatic MRI T2* (STAR) sequence, were retrospectively assessed. A total of 29 patients were enrolled. Results Hypothyroidism was detected in 34.6% (9/26) of patients, short stature in 37% (10/27), and pubertal retardation in 50% (14/28) of the patients. There was no significant correlation between hypothyroidism and pituitary MRI T2* values. No significant correlation was found between laboratory parameters and pituitary MRI examination. Although the sensitivity of T2* levels could rise above 80%, their specificity remained low. This is one of the major limitations of the pituitary MR T2* study for the prediction of short stature. The best lower cut-off level of MR T2* to predict short stature was found 14.6 ms. Conclusion The diagnostic specificity pituitary MR examination levels for short stature were detected as low. Thus, the clinical standardization and validation of pituitary MR T2* values examination are needed before clinical follow-up and multifaceted studies are needed.
Copyright © 2021, Yılmaz et al.

Entities:  

Keywords:  beta thalassemia; pituitary mri; siderosis; t2

Year:  2021        PMID: 33633906      PMCID: PMC7899051          DOI: 10.7759/cureus.12877

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  28 in total

1.  Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance.

Authors:  Timothy G St Pierre; Paul R Clark; Wanida Chua-anusorn; Adam J Fleming; Gary P Jeffrey; John K Olynyk; Pensri Pootrakul; Erin Robins; Robert Lindeman
Journal:  Blood       Date:  2004-07-15       Impact factor: 22.113

2.  Evaluation of the relationship between splenic iron overload and liver, heart and muscle features evident on T2*-weighted magnetic resonance imaging.

Authors:  Mehmet Güli Çetinçakmak; Salih Hattapoğlu; Murat Söker; Faysal Ekici; Kamil Yilmaz; Cemil Göya; Cihad Hamidi
Journal:  Adv Clin Exp Med       Date:  2020-04       Impact factor: 1.727

3.  Iron overload detection using pituitary and hepatic MRI in thalassemic patients having short stature and hypogonadism.

Authors:  Amany A Mousa; Mohamed Ghonem; El Hadidy M Elhadidy; Emad Azmy; Magda Elbackry; Azza A Elbaiomy; Rasha R Elzehery; Gehan A Shaker; Omyma Saleh
Journal:  Endocr Res       Date:  2016-01-04       Impact factor: 1.720

Review 4.  Growth and puberty and its management in thalassaemia.

Authors:  V De Sanctis
Journal:  Horm Res       Date:  2002

5.  Effect of different treatment regimes on linear growth and final height in beta-thalassaemia major.

Authors:  V De Sanctis; M Katz; C Vullo; B Bagni; M Ughi; B Wonke
Journal:  Clin Endocrinol (Oxf)       Date:  1994-06       Impact factor: 3.478

6.  Deferoxamine-induced growth retardation in patients with thalassemia major.

Authors:  S De Virgiliis; M Congia; F Frau; F Argiolu; G Diana; F Cucca; A Varsi; G Sanna; G Podda; M Fodde
Journal:  J Pediatr       Date:  1988-10       Impact factor: 4.406

Review 7.  Reproductive health in young male adults with chronic diseases in childhood.

Authors:  Vincenzo De Sanctis; Ashraf Soliman; Yassin Mohamed
Journal:  Pediatr Endocrinol Rev       Date:  2013 Mar-Apr

8.  Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major.

Authors:  Kallistheni Farmaki; Ioanna Tzoumari; Christina Pappa; Giorgos Chouliaras; Vasilios Berdoukas
Journal:  Br J Haematol       Date:  2009-11-12       Impact factor: 6.998

9.  Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran.

Authors:  Alireza Abdollah Shamshirsaz; Mir Reza Bekheirnia; Mohammad Kamgar; Nima Pourzahedgilani; Navid Bouzari; Mohammadreza Habibzadeh; Reza Hashemi; Amirhooshang Abdollah Shamshirsaz; Shahriar Aghakhani; Hooman Homayoun; Bagher Larijani
Journal:  BMC Endocr Disord       Date:  2003-08-12       Impact factor: 2.763

Review 10.  Hypogonadism in thalassemia major patients.

Authors:  Sasima Srisukh; Boonsong Ongphiphadhanakul; Pongamorn Bunnag
Journal:  J Clin Transl Endocrinol       Date:  2016-08-16
View more
  1 in total

1.  GH/IGF-1 axis in a large cohort of ß-thalassemia major adult patients: a cross-sectional study.

Authors:  I Gagliardi; R Mungari; M R Gamberini; M Fortini; F Dassie; M C Putti; P Maffei; L Aliberti; M Bondanelli; M C Zatelli; M R Ambrosio
Journal:  J Endocrinol Invest       Date:  2022-03-19       Impact factor: 5.467

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.